Home
Arbutus Biopharma

Arbutus Biopharma Market Share Analysis for February 2026

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania.

Health > Biotechnology and Pharmaceuticals

Domainarbutusbio.com

Year Founded2005

Employees51 - 200

Annual Revenue$10M - $15M

Arbutus Biopharma

Arbutus Biopharma (including company regionals)

arbutusbio.com

See more website traffic and engagement information

Arbutus Biopharma Revenue up to February 2026 is 10M - 15M

revenue generated by Arbutus Biopharma top domains

Arbutus Biopharma top domains revenue over 3 years

Revenue for Arbutus Biopharma top domains

arbutusbio.com10M - 15M

See more with Sales Intelligence

Total visits to Arbutus Biopharma's top domains

Understand Arbutus Biopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

arbutusbio.com6.7K

See more with Sales Intelligence

Avg. visit duration in Arbutus Biopharma's top domains

Analyze Arbutus Biopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

arbutusbio.com00:00:24

See more with Sales Intelligence

Avg. pageviews on Arbutus Biopharma's top domains

See how Arbutus Biopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

arbutusbio.com1.66

See more with Sales Intelligence

Arbutus Biopharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Arbutus Biopharma

These are the website technologies, by industry, used by Arbutus Biopharma top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Social (2)

Facebook Social Plugins

More Technologies

7

See all

News & Signals from Arbutus Biopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArbutus Biopharma Corporation partnered with Moderna Therapeutics Inc. on Mar 3rd '26.In a press release issued on Tuesday, Genevant Sciences and Arbutus Biopharma announced they have entered into a global settlement with Moderna, Inc. that could result in a payment of up to $2.5 billion.

NewsArbutus Biopharma Corporation attends event AASLD 2025.Arbutus Biopharma to present new data on imdusiran and AB-101 at AASLD 2025.

NewsArbutus Biopharma Corporation launches Scientific Advisory Board.Arbutus has also launched a new Scientific Advisory Board (SAB) consisting of globally recognized leaders in the treatment of chronic hepatitis B virus (cHBV) with extensive experience in late-stage clinical trials.